Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced ...

Americans curious about their ancestry likely paid for a DNA test through 23andMe. But with their future unclear, what will ...

23andMe, named because of the number of chromosome pairs in human DNA, raised more than $1.1bn before its hotly awaited IPO ...

Concerns have been raised about how 23andMe could potentially handle customer information due to the company’s uncertain ...

About 23andMe 23andMe is a genetics-led consumer ... or an inability to increase the stock price in an amount sufficient to satisfy compliance with the Nasdaq’s minimum closing bid price ...

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), announced today the completion of the previously announced 1-for-20 reverse stock sp ...

According to InvestingPro data, 23andMe's stock has experienced a substantial decline, with a 1-year price total return of -69.61% as of the most recent data. This downward trend is further ...

According to InvestingPro data, 23andMe's stock has experienced a substantial decline, with a 1-year price total return of -69.61% as of the most recent data. This downward trend is further emphasized ...

23andMe is a genetics-led consumer healthcare and therapeutics ... or an inability to increase the stock price in an amount sufficient to satisfy compliance with the Nasdaq’s minimum ...